Literature DB >> 27506813

Morphine enhances IL-1β release through toll-like receptor 4-mediated endocytic pathway in microglia.

Yongxin Liang1, Haichen Chu2, Yanan Jiang2, Li Yuan2.   

Abstract

Morphine creates a neuroinflammatory response and enhances release of the proinflammatory cytokines like interleukin-1β (IL-1β), which compromises morphine analgesia as well as induces morphine tolerance. In this study, we attempted to investigate the mechanisms of morphine induced IL-1β synthesis and release. Microglial cells were treated with morphine (100 μM) once daily for 3 days. Control groups underwent the same procedure but received sterile saline injection instead of morphine. Toll-like receptor 4 (TLR4) and P2X4 receptor (P2X4R) signaling were analyzed using Western blot; immunofluorescence was used to detect the signaling of CD68; real-time RT-PCR and ELISA kit was used to measure the messenger RNA and protein synthesis and release level of IL-1β. Morphine enhanced IL-1β synthesis and P2X4R protein expression. TLR4 were responsible for morphine-induced IL-1β synthesis, while morphine-induced IL-1β release was via P2X4R. Morphine-induced IL-1β release is mediated by endocytosis of TLR4. These results indicated that TLR4 and P2X4R pathways mediated IL-1β synthesis and release in microglia followed chronic morphine. TLR4 internalization is the main mechanism of morphine-induced microglia activation and IL-1β release.

Entities:  

Keywords:  Interleukin-1β; Microglia; Morphine; P2X4 receptors; Toll-like receptor 4

Mesh:

Substances:

Year:  2016        PMID: 27506813      PMCID: PMC5124002          DOI: 10.1007/s11302-016-9525-4

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  46 in total

Review 1.  Neuronal 'On' and 'Off' signals control microglia.

Authors:  Knut Biber; Harald Neumann; Kazuhide Inoue; Hendrikus W G M Boddeke
Journal:  Trends Neurosci       Date:  2007-10-24       Impact factor: 13.837

2.  Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity.

Authors:  Harald Husebye; Øyvind Halaas; Harald Stenmark; Gro Tunheim; Øystein Sandanger; Bjarne Bogen; Andreas Brech; Eicke Latz; Terje Espevik
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

3.  Deletion of the murine scavenger receptor CD68.

Authors:  Li Song; Carolyn Lee; Christian Schindler
Journal:  J Lipid Res       Date:  2011-05-13       Impact factor: 5.922

4.  Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice.

Authors:  Gilly Wolf; Eran Gabay; Michael Tal; Raz Yirmiya; Yehuda Shavit
Journal:  Pain       Date:  2006-01-19       Impact factor: 6.961

Review 5.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

6.  Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes.

Authors:  B D Humphreys; G R Dubyak
Journal:  J Leukoc Biol       Date:  1998-08       Impact factor: 4.962

7.  Microglial activation involved in morphine tolerance is not mediated by toll-like receptor 4.

Authors:  Hiroshi Fukagawa; Tomohiro Koyama; Masahiro Kakuyama; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2012-08-25       Impact factor: 2.078

8.  Evidence that opioids may have toll-like receptor 4 and MD-2 effects.

Authors:  Mark R Hutchinson; Yingning Zhang; Mitesh Shridhar; John H Evans; Madison M Buchanan; Tina X Zhao; Peter F Slivka; Benjamen D Coats; Niloofar Rezvani; Julie Wieseler; Travis S Hughes; Kyle E Landgraf; Stefanie Chan; Stephanie Fong; Simon Phipps; Joseph J Falke; Leslie A Leinwand; Steven F Maier; Hang Yin; Kenner C Rice; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2009-08-11       Impact factor: 7.217

9.  P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages.

Authors:  S E Hickman; J el Khoury; S Greenberg; I Schieren; S C Silverstein
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

10.  Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.

Authors:  C W Stevens; S Aravind; S Das; R L Davis
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

View more
  18 in total

1.  Quercetin inhibits gout arthritis in mice: induction of an opioid-dependent regulation of inflammasome.

Authors:  Kenji W Ruiz-Miyazawa; Larissa Staurengo-Ferrari; Sandra S Mizokami; Talita P Domiciano; Fabiana T M C Vicentini; Doumit Camilios-Neto; Wander R Pavanelli; Phileno Pinge-Filho; Flávio A Amaral; Mauro M Teixeira; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflammopharmacology       Date:  2017-05-15       Impact factor: 4.473

2.  Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.

Authors:  Xiaohui Wang; Alexis L Northcutt; Thomas A Cochran; Xiaozheng Zhang; Timothy J Fabisiak; Mackenzie E Haas; Jose Amat; Hongyuan Li; Kenner C Rice; Steven F Maier; Ryan K Bachtell; Mark R Hutchinson; Linda R Watkins
Journal:  ACS Chem Neurosci       Date:  2019-07-17       Impact factor: 4.418

Review 3.  Canonical and non-canonical autophagy pathways in microglia.

Authors:  Julia Jülg; Laura Strohm; Christian Behrends
Journal:  Mol Cell Biol       Date:  2020-11-02       Impact factor: 4.272

4.  Brief Report: IL-1β Levels Are Associated With Chronic Multisite Pain in People Living With HIV.

Authors:  Jessica S Merlin; Andrew O Westfall; Sonya L Heath; Burel R Goodin; Jesse C Stewart; Robert E Sorge; Jarred Younger
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-01       Impact factor: 3.731

Review 5.  Glial and neuroinflammatory targets for treating substance use disorders.

Authors:  Ryan K Bachtell; Jermaine D Jones; Keith G Heinzerling; Patrick M Beardsley; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

Review 6.  Glial neuroimmune signaling in opioid reward.

Authors:  Hong Zhang; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Brain Res Bull       Date:  2019-11-29       Impact factor: 4.077

7.  Inflammasome in drug abuse.

Authors:  Enquan Xu; Jianuo Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

8.  The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety.

Authors:  Jermaine D Jones; Adam Bisaga; Verena E Metz; Jeanne M Manubay; Shanthi Mogali; Roberto Ciccocioppo; Gabriela Madera; Molly Doernberg; Sandra D Comer
Journal:  J Psychoactive Drugs       Date:  2018-09-11

9.  Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke.

Authors:  Pranay Srivastava; Chunxia G Cronin; Victoria L Scranton; Kenneth A Jacobson; Bruce T Liang; Rajkumar Verma
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

Review 10.  Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response.

Authors:  Clare T Johnson; Heather B Bradshaw
Journal:  Cannabis Cannabinoid Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.